05069cam a22004818i 4500 22419368 BJBSDDR 20240507114916.0 m |o d | ta 220207s2022 mau 001 0 eng 2022001932 9781647823207 (epub) 9781647823191 (hardcover) DLC spa DLC rda eng pcc HD 9668.5 L829m 2022 338.4/76153 23/eng/20220210 Lotus,Peter (Peter D.), author. 35513 The messenger : Moderna, the vaccine, and the business gamble that changed the world / Peter Loftus. 2207 Boston, Massachusetts : Harvard Business Review Press, [2022] 307 page. 24 cm text txt rdacontent computer c rdamedia online resource cr rdacarrier Includes index. Prologue. Disease X -- Changing the Fate -- If This Is True -- Kendall Square -- Feeding the Beast -- Broke Offer -- No Boundaries -- mRNA- -- More Money -- Warp Speed -- Hold On, Help Is On the Way -- Politics Protocols and Patents -- The Power of Science -- Evidence -- Happy Tears -- Delta -- Just the Beginning. "At the start of 2020, Moderna was a waning biotech unicorn, still years away from delivering its first product despite a decade of development of a potentially breakthrough innovation: using RNA to combat disease. Investors were getting antsy or, worse, skeptical. Then the coronavirus pandemic hit, and Moderna became a central player in a global drama-a David to pharma's Goliaths-turning its technology toward breaking the global grip of the terrible disease. By year's end, as the outbreak was at its worst, Moderna delivered one of the world's first Covid-19 vaccines, with a stunningly high rate of protection. The achievement not only offered the world a way out of a crippling pandemic but also validated Moderna's gene-based technology, transforming the company into a global industry power, swelling its market value on its prospects for new drugs and vaccines for years to come. Biotech, and the venture capital community that fuels it, will never be the same. Wall Street Journal reporter Peter Loftus, part of a Pulitzer Prize-finalist reporting team and 25-year veteran reporter in the pharmaceutical and biotech industries, brings the inside story of how Moderna went all in on a single revolutionary idea; of quiet research with unknown consequence; of the evolution of a cutting-edge American innovation, industry, and economy-decades in the making-that led to one of the great gambles in business history"-- Provided by publisher. Description based on print version record and CIP data provided by publisher; resource not viewed. Moderna (Firm) History. Vaccines industry History. Industria farmacéutica Vacunas Historia 32400 Pharmaceutical biotechnology industry Economic aspects History. Industria farmacéutica Aspectos económicos Historia 32400 Messenger RNA. ARN mensajero 35745 Print version: Loftus, Peter Messenger Boston, Massachusetts : Harvard Business Review Press, [2022] 9781647823191 (DLC) 2022001931 7 cbc orignew 1 ecip 20 y-gencatlg lcc BK 0 121136 121136 0 0 lcc 0 0 CS BJB BJB CS 2024-04-24 0 HD 9668.5 L829m 2022 00000173668 2024-04-24 00:00:00 1 2024-04-24 BK